Mazzotta A - Search Results

1

Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.

Mazzotta A, Esposito M, Costanzo A, Chimenti S. Mazzotta A, et al. Am J Clin Dermatol. 2009;10(5):319-24. doi: 10.2165/11310770-000000000-00000. Am J Clin Dermatol. 2009. PMID: 19658444 Clinical Trial.

2

Long-term experience with etanercept in psoriatic arthritis patients: a 3-year observational study.

Mazzotta A, Esposito M, Schipani C, Chimenti S. Mazzotta A, et al. J Dermatolog Treat. 2009;20(6):354-8. doi: 10.3109/09546630902936752. J Dermatolog Treat. 2009. PMID: 19954392 Free article. Clinical Trial.

3

TNF-α antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasis.

Saraceno R, Pietroleonardo L, Mazzotta A, Zangrilli A, Bianchi L, Chimenti S. Saraceno R, et al. Among authors: mazzotta a. Expert Opin Biol Ther. 2013 Apr;13(4):469-73. doi: 10.1517/14712598.2013.736960. Epub 2012 Nov 16. Expert Opin Biol Ther. 2013. PMID: 23157654 Clinical Trial.

4

Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.

Esposito M, Giunta A, Mazzotta A, Zangrilli A, Babino G, Bavetta M, Perricone R, Chimenti S, Chimenti MS. Esposito M, et al. Among authors: mazzotta a. Dermatology. 2012;225(4):312-9. doi: 10.1159/000345623. Epub 2012 Dec 28. Dermatology. 2012. PMID: 23295383

5

Clinical markers predictive of primary inefficacy: a "real life" retrospective study in psoriatic patients treated with etanercept.

Giunta A, Babino G, Manetta S, Mazzotta A, Chimenti S, Esposito M. Giunta A, et al. Among authors: mazzotta a. Drug Dev Res. 2014 Nov;75 Suppl 1:S27-30. doi: 10.1002/ddr.21206. Drug Dev Res. 2014. PMID: 25381970

6

Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis.

Mazzotta A, Esposito M, Carboni I, Schipani C, Chimenti S. Mazzotta A, et al. J Dermatolog Treat. 2007;18(2):84-7. doi: 10.1080/09546630601123835. J Dermatolog Treat. 2007. PMID: 17520464 Free article. Clinical Trial.

7

High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: efficacy, safety and impact on patients' quality of life.

De Felice C, Mazzotta A, Esposito M, Bianchi L, Chimenti S. De Felice C, et al. Among authors: mazzotta a. J Dermatolog Treat. 2006;17(6):355-8. doi: 10.1080/09546630601028703. J Dermatolog Treat. 2006. PMID: 17853309 Free article. Clinical Trial.

8

Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis.

Saraceno R, Schipani C, Mazzotta A, Esposito M, Di Renzo L, De Lorenzo A, Chimenti S. Saraceno R, et al. Among authors: mazzotta a. Pharmacol Res. 2008 Apr;57(4):290-5. doi: 10.1016/j.phrs.2008.02.006. Epub 2008 Feb 29. Pharmacol Res. 2008. PMID: 18400510

9

Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients.

Campione E, Mazzotta A, Paternò EJ, Diluvio L, Prinz JC, Chimenti S. Campione E, et al. Among authors: mazzotta a. Acta Derm Venereol. 2009;89(3):288-91. doi: 10.2340/00015555-0585. Acta Derm Venereol. 2009. PMID: 19479128 Free article.

10

Safety and efficacy study on etanercept in patients with plaque psoriasis.

Costanzo A, Mazzotta A, Papoutsaki M, Nisticò S, Chimenti S. Costanzo A, et al. Among authors: mazzotta a. Br J Dermatol. 2005 Jan;152(1):187-9. doi: 10.1111/j.1365-2133.2005.06306.x. Br J Dermatol. 2005. PMID: 15656833 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters